| scholarly article | Q13442814 |
| P356 | DOI | 10.4161/HV.20528 |
| P698 | PubMed publication ID | 22777092 |
| P50 | author | Anne Searls De Groot | Q16224732 |
| Soren Buus | Q43114589 | ||
| Kenneth Mayer | Q54230575 | ||
| Lauren Levitz | Q56801988 | ||
| William D Martin | Q57544007 | ||
| Matthew T Ardito | Q117249450 | ||
| Gail Skowron | Q117269454 | ||
| P2093 | author name string | Christine M. Boyle | |
| P2860 | cites work | Design and pre-clinical evaluation of a universal HIV-1 vaccine | Q21092234 |
| Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response | Q21131580 | ||
| Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations | Q24612449 | ||
| A DNA vaccine encoding multiple HIV CD4 epitopes elicits vigorous polyfunctional, long-lived CD4+ and CD8+ T cell responses | Q28742853 | ||
| Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand | Q29547531 | ||
| Immune-correlates analysis of an HIV-1 vaccine efficacy trial | Q29617377 | ||
| Clinical trials of HIV vaccines. | Q30329521 | ||
| Thirty years of HIV and AIDS: future challenges and opportunities | Q30403293 | ||
| HIV-1 group M conserved elements vaccine | Q33308246 | ||
| HLA class I supertypes: a revised and updated classification | Q33315730 | ||
| HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins | Q33494829 | ||
| In vivo CD8+ T-cell suppression of siv viremia is not mediated by CTL clearance of productively infected cells | Q33618013 | ||
| Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys | Q33712291 | ||
| Identification and characterization of HLA-A*0301 epitopes in HIV-1 gag proteins using a novel approach | Q33717999 | ||
| Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection | Q33828583 | ||
| Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design | Q33845527 | ||
| Nef-specific CD45RA+ CD8+ T cells secreting MIP-1beta but not IFN-gamma are associated with nonprogressive HIV-1 infection. | Q34016464 | ||
| Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution | Q34092644 | ||
| Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory | Q34190038 | ||
| From genome to vaccine: in silico predictions, ex vivo verification. | Q34324993 | ||
| Adaptation of HIV-1 to human leukocyte antigen class I | Q34604811 | ||
| Lessons drawn from recent HIV vaccine efficacy trials | Q34816639 | ||
| Requirement of diverse T-helper responses elicited by HIV vaccines: induction of highly targeted humoral and CTL responses | Q35851778 | ||
| Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype | Q36022184 | ||
| Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation. | Q36377141 | ||
| HLA class I-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral load | Q36748059 | ||
| Identification of immunogenic HLA-B7 "Achilles' heel" epitopes within highly conserved regions of HIV | Q36910003 | ||
| Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities | Q36954486 | ||
| HLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infection | Q37051649 | ||
| Extensive HLA class I allele promiscuity among viral CTL epitopes | Q37066721 | ||
| Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1. | Q37099792 | ||
| HLA footprints on human immunodeficiency virus type 1 are associated with interclade polymorphisms and intraclade phylogenetic clustering | Q37157122 | ||
| Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells | Q37256675 | ||
| T-cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces | Q37333743 | ||
| Lessons learned from natural infection: focusing on the design of protective T cell vaccines for HIV/AIDS. | Q37678701 | ||
| Fitness costs limit viral escape from cytotoxic T lymphocytes at a structurally constrained epitope | Q37683431 | ||
| Inter-clade cross-reactivity of HIV-1-specific T cell responses in human immunodeficiency virus type 1 infection in China | Q40235980 | ||
| Enhanced anti-HIV functional activity associated with Gag-specific CD8 T-cell responses | Q40757015 | ||
| Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro | Q40863632 | ||
| Ex vivo expansion of HIV type 1-specific cytolytic T cells from HIV type 1-seropositive subjects | Q41376652 | ||
| Increasing CTL targeting of conserved sequences during early HIV-1 infection is correlated to decreasing viremia | Q42738531 | ||
| Coping with viral diversity in HIV vaccine design: a response to Nickle et al. | Q42979227 | ||
| Comparison of immunogen designs that optimize peptide coverage: reply to Fischer et al. | Q42979247 | ||
| Spreading of HIV-specific CD8+ T-cell repertoire in long-term nonprogressors and its role in the control of viral load and disease activity | Q44300776 | ||
| The organization of human leucocyte antigen class I epitopes in HIV genome products: implications for HIV evolution and vaccine design | Q44439324 | ||
| Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection | Q44519261 | ||
| An interactive Web site providing major histocompatibility ligand predictions: application to HIV research | Q45149920 | ||
| Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine | Q45382232 | ||
| Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation | Q45413707 | ||
| Screening for CD8 cytotoxic T lymphocytes specific for Gag of human immunodeficiency virus type 1 subtype B' Henan isolate from China and identification of novel epitopes restricted by the HLA-A2 and HLA-A11 alleles | Q45421518 | ||
| Key issues for a potential human immunodeficiency virus vaccine | Q45729083 | ||
| Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity | Q45729365 | ||
| Transition from long-term nonprogression to HIV-1 disease associated with escape from cellular immune control. | Q46165080 | ||
| HIV-1-specific cytotoxic T lymphocyte (CTL) responses against immunodominant optimal epitopes slow the progression of AIDS in China | Q46174165 | ||
| Confirmation of immunogenic consensus sequence HIV-1 T-cell epitopes in Bamako, Mali and Providence, Rhode Island | Q46214853 | ||
| Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells. | Q50960985 | ||
| Broadly immunogenic HLA class I supertype-restricted elite CTL epitopes recognized in a diverse population infected with different HIV-1 subtypes. | Q51890327 | ||
| Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants. | Q51926211 | ||
| An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais. | Q52059829 | ||
| Establishment of a quantitative ELISA capable of determining peptide - MHC class I interaction | Q56999959 | ||
| CD8+ T-cell responses to different HIV proteins have discordant associations with viral load | Q57259602 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 987-1000 | |
| P577 | publication date | 2012-07-01 | |
| P1433 | published in | Human Vaccines & Immunotherapeutics | Q21072749 |
| P1476 | title | Further progress on defining highly conserved immunogenic epitopes for a global HIV vaccine: HLA-A3-restricted GAIA vaccine epitopes | |
| P478 | volume | 8 |
| Q92132618 | Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools |
| Q37713379 | Comparative genomics and immunoinformatics approach for the identification of vaccine candidates for enterohemorrhagic Escherichia coli O157:H7. |
| Q36467153 | Conservation of HIV-1 T cell epitopes across time and clades: validation of immunogenic HLA-A2 epitopes selected for the GAIA HIV vaccine |
| Q40476246 | Hit-and-run, hit-and-stay, and commensal bacteria present different peptide content when viewed from the perspective of the T cell. |
| Q30222126 | Making vaccines "on demand": a potential solution for emerging pathogens and biodefense? |
| Q41988381 | Structure-based redesign of proteins for minimal T-cell epitope content |
| Q30352021 | Universal H1N1 influenza vaccine development: identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011. |
| Q37119456 | Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century |
| Q41117694 | iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines. |
Search more.